Stomach Diseases  >>  everolimus  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
everolimus / Generic mfg.
GRANITE-1, NCT00879333 / 2008-006544-20: Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)

Checkmark In previously treated adv gastric cancer pts
Sep 2013 - Sep 2013: In previously treated adv gastric cancer pts
Checkmark P3 data - ESMO 2012
Sep 2012 - Sep 2012: P3 data - ESMO 2012
Checkmark P3 data - ESMO
More
Completed
3
656
Japan, US, Canada, Europe, RoW
Everolimus, RAD001, Everolimus placebo, Best Supportive Care (BSC)
Novartis Pharmaceuticals
Advanced Gastric Cancer
01/14
01/14

Download Options